CytomX Therapeutics Inc at Barclays Global Healthcare Conference Transcript
So good afternoon, everybody, and welcome to Barclays Healthcare Conference in Miami. Do raise a hand or ping myself or one of my associates if you have questions that need to be addressed. My name is Peter Lawson. I'm one of the biotech analysts at Barclays. I cover mid-cap oncology biotech companies. Really delighted to have up on the stage with me, Sean McCarthy from CytomX.
Questions & Answers
And first question really is kind of the -- I guess the differentiating factor that we have around your approach, kind of, how is that resonating in the sense of partnerships and how partners are perceiving that activation of kind of a prodrug antibody?
Yes. Thanks, Peter, and pleasure to be here. Thanks for the invitation. So just to briefly recap the core technology that we've been developing
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
